Cargando…

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide

Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For exampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Murase-Mishiba, Yuko, Imagawa, A., Hanafusa, Toshiaki
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323619/
https://www.ncbi.nlm.nih.gov/pubmed/18437231
http://dx.doi.org/10.1155/2008/819123
_version_ 1782152671908593664
author Murase-Mishiba, Yuko
Imagawa, A.
Hanafusa, Toshiaki
author_facet Murase-Mishiba, Yuko
Imagawa, A.
Hanafusa, Toshiaki
author_sort Murase-Mishiba, Yuko
collection PubMed
description Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For example, patients with fulminant type 1 diabetes have diabetic chronic complications more frequently than those with classical autoimmune type 1 diabetes 5 years after the onset of diabetes, and the higher prevalence could be partly attributable to the complete lack of C-peptide in fulminant type 1 diabetes.
format Text
id pubmed-2323619
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23236192008-04-24 Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide Murase-Mishiba, Yuko Imagawa, A. Hanafusa, Toshiaki Exp Diabetes Res Review Article Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For example, patients with fulminant type 1 diabetes have diabetic chronic complications more frequently than those with classical autoimmune type 1 diabetes 5 years after the onset of diabetes, and the higher prevalence could be partly attributable to the complete lack of C-peptide in fulminant type 1 diabetes. Hindawi Publishing Corporation 2008 2008-04-15 /pmc/articles/PMC2323619/ /pubmed/18437231 http://dx.doi.org/10.1155/2008/819123 Text en Copyright © 2008 Yuko Murase-Mishiba et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Murase-Mishiba, Yuko
Imagawa, A.
Hanafusa, Toshiaki
Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title_full Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title_fullStr Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title_full_unstemmed Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title_short Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
title_sort fulminant type 1 diabetes as a model of nature to explore the role of c-peptide
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323619/
https://www.ncbi.nlm.nih.gov/pubmed/18437231
http://dx.doi.org/10.1155/2008/819123
work_keys_str_mv AT murasemishibayuko fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide
AT imagawaa fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide
AT hanafusatoshiaki fulminanttype1diabetesasamodelofnaturetoexploretheroleofcpeptide